Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis

Ann Surg Oncol. 2017 Aug;24(8):2069-2070. doi: 10.1245/s10434-017-5862-y. Epub 2017 May 26.

Authors

Matin Imanguli¹, Baran D Sumer²

Affiliations

¹ Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
² Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA. Baran.Sumer@UTSouthwestern.edu.

PMID: 28550487
DOI: 10.1245/s10434-017-5862-y

No abstract available

Publication types

Editorial

MeSH terms

Carcinoma, Adenoid Cystic / mortality*
Carcinoma, Adenoid Cystic / therapy
Head and Neck Neoplasms / mortality*
Head and Neck Neoplasms / therapy
Humans
Prognosis
Risk Assessment
SEER Program
Salivary Gland Neoplasms / mortality
Salivary Gland Neoplasms / therapy
United States / epidemiology